Overview

Pirfenidone Effect on the Recovery of Renal Function in Septic Acute Kidney Injury

Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Patients with Septic AKI will be randomized in three arms, group PFD 1,200 will receive PDF 600mg every 12 hrs per mouth, group PDF 600 will receive PFD 600mg in the morning and placebo equivalent at night and Group Placebo will receive placebo every 12 hrs, all for 7 days, all receive conventional treatment KDIGO guides. We analyze the recovery of renal function as a primary objective.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Civil de Guadalajara
Treatments:
Pirfenidone